Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
In this 10-minute educational video, Dr. Stefania Morganti from Dana-Farber Cancer Institute's Breast Oncology Program explains the role of circulating tumor DNA (ctDNA) in detecting minimal residual disease in early stage breast cancer patients. Learn about this important diagnostic tool and how it's being utilized to improve treatment outcomes and patient monitoring in early breast cancer cases.
